| 臺大學術典藏 |
2020-11-03T11:57:00Z |
Effect of Kidney Dysfunction on Cerebral Cortical Thinning in Elderly Population
|
Chen C.-H.; Chen Y.-F.; Ming-Jang Chiu; Chen T.-F.; Tsai P.-H.; Chen J.-H.; Yen C.-J.; Tang S.-C.; Yeh S.-J.; Chen Y.-C.; Chen C.-H.; MING-JANG CHIU et al. |
| 臺大學術典藏 |
2020-11-03T11:20:32Z |
Effect of Kidney Dysfunction on Cerebral Cortical Thinning in Elderly Population
|
Chen Y.-C.; Yeh S.-J.; Tang S.-C.; Chen C.-H.;Chen Y.-F.;Chiu M.-J.;Ta-Fu Chen;Tsai P.-H.;Chen J.-H.;Yen C.-J.;Tang S.-C.;Yeh S.-J.;Chen Y.-C.; Chen C.-H.; Chen Y.-F.; Chiu M.-J.; TA-FU CHEN; Tsai P.-H.; Chen J.-H.; Yen C.-J. |
| 臺大學術典藏 |
2020-11-03T11:08:06Z |
Effect of Kidney Dysfunction on Cerebral Cortical Thinning in Elderly Population
|
Chen C.-H.;Chen Y.-F.;Chiu M.-J.;Chen T.-F.;Tsai P.-H.;Chen J.-H.;Yen C.-J.;Sung-Chun Tang;Yeh S.-J.;Chen Y.-C.; Chen C.-H.; Chen Y.-F.; Chiu M.-J.; Chen T.-F.; Tsai P.-H.; Chen J.-H.; Yen C.-J.; SUNG-CHUN TANG; Yeh S.-J.; Chen Y.-C. |
| 臺大學術典藏 |
2020-10-15T03:58:08Z |
Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: Systematic review and meta-analysis
|
Kuo H.-K.; Yen C.-J.; CHIA-HSUIN CHANG; Kuo C.-K.; Chen J.-H.; Sorond F. |
| 臺大學術典藏 |
2020-10-15T03:57:49Z |
Antihypertensive agents and the risk of breast cancer in women aged 55 years and older: A nested case-control study
|
CHIA-HSUIN CHANG; Chiang C.-H.; Yen C.-J.; Wu L.-C.; Lin J.-W.; Lai M.-S. |
| 臺大學術典藏 |
2020-10-15T03:57:43Z |
Immediate knowledge improvement and long-term teaching confidence after general medicine faculty training program
|
Chang P.-Y.; Tseng F.-Y.; Lin L.-C.; Ko B.-S.; Chu T.-S.; Tsai S.-L.; Sheng W.-H.; Yen C.-J.; CHIA-HSUIN CHANG; Wu C.-H.; Shih S.-R.; Chiu W.-Y.; Pan S.-C.; Chen W.-P. |
| 臺大學術典藏 |
2020-09-30T02:30:07Z |
Immediate knowledge improvement and long-term teaching confidence after general medicine faculty training program
|
Tseng F.-Y.;Lin L.-C.;Ko B.-S.;Chu T.-S.;Tsai S.-L.;Sheng W.-H.;Yen C.-J.;Chang C.-H.;Wu C.-H.;Shih S.-R.;Chiu W.-Y.;Sung-Ching Pan;Chen W.-P.;Chang P.-Y.; Tseng F.-Y.; Lin L.-C.; Ko B.-S.; Chu T.-S.; Tsai S.-L.; SUNG-CHING PAN; Chen W.-P.; Chang P.-Y.; Sheng W.-H.; Yen C.-J.; Chang C.-H.; Wu C.-H.; Shih S.-R.; Chiu W.-Y. |
| 臺大學術典藏 |
2020-09-23T08:35:44Z |
Effect of Kidney Dysfunction on Cerebral Cortical Thinning in Elderly Population
|
Chen C.-H.; YA-FANG CHEN; Chiu M.-J.; Chen T.-F.; Tsai P.-H.; Chen J.-H.; Yen C.-J.; Tang S.-C.; Yeh S.-J.; Chen Y.-C. |
| 臺大學術典藏 |
2020-08-21T08:50:59Z |
Metabolic risks, white matter hyperintensities, and arterial stiffness in high-functioning healthy adults
|
Yen C.-J.; Chen C.-Y.; HON-MAN LIU; Kuo H.-K.; Chang K.-J.; Chang C.-C.; Yu Y.-H.; Lin L.-Y.; Hwang J.-J. |
| 臺大學術典藏 |
2020-08-14T03:15:30Z |
Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
|
Lu L.-C.; Hsu C.; Shao Y.-Y.; Chao Y.; Yen C.-J.; I-LUN SHIH; Hung Y.-P.; Chang C.-J.; Shen Y.-C.; Guo J.-C.; Liu T.-H.; Hsu C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-08-13T06:33:32Z |
Ramucirumab safety in East Asian patients: A meta-analysis of six global, randomized, double-blind, placebo-controlled, phase III clinical trials
|
Zhang Y.; Sohn J.; Cheng R.; Yamazaki K.; Kim S.-W.; Chao Y.; Lee K.-W.; JIN-YUAN SHIH; Kudo M.; Kim T.-W.; Muro K.; Yen C.-J.; Yen C.-J.;Muro K.;Kim T.-W.;Kudo M.;Jin-Yuan Shih;Lee K.-W.;Chao Y.;Kim S.-W.;Yamazaki K.;Sohn J.;Cheng R.;Zhang Y.;Binder P.;Mi G.;Orlando M.;Chung H.C.; Binder P.; Mi G.; Orlando M.; Chung H.C. |
| 臺大學術典藏 |
2020-08-06T06:06:57Z |
Shared risk factors for distinct geriatric syndromes in older Taiwanese inpatients
|
CHARLOTTE WANG; Chen C.C.-H.;Dai Y.-T.;Yen C.-J.;Huang G.-H.;Charlotte Wang; Chen C.C.-H.; Dai Y.-T.; Yen C.-J.; Huang G.-H. |
| 臺大學術典藏 |
2020-08-05T00:38:52Z |
Hyperuricemia Associated With Rapid Renal Function Decline in Elderly Taiwanese Subjects
|
Yen C.-J.; Chiang C.-K.; Ho L.-C.; SANDY HUEY-JEN HSU; Hung K.-Y.; Wu K.-D.; Tsai T.-J. |
| 臺大學術典藏 |
2020-06-18T00:56:09Z |
Interaction of the G182C polymorphism in the APOA5 gene and fasting plasma glucose on plasma triglycerides in Type 2 diabetic subjects
|
Yi-Der Jiang;Yen C.-J.;Chou W.-L.;Kuo S.-S.;Lee K.-C.;Chiu K.C.;Chuang L.-M.; YI-DER JIANG; Yen C.-J.; Chou W.-L.; Kuo S.-S.; Lee K.-C.; Chiu K.C.; Chuang L.-M. |
| 臺大學術典藏 |
2020-06-17T06:20:56Z |
Interaction of the G182C polymorphism in the APOA5 gene and fasting plasma glucose on plasma triglycerides in Type 2 diabetic subjects
|
YI-DER JIANG;Chuang L.-M.;Chiu K.C.;Lee K.-C.;Kuo S.-S.;Chou W.-L.;Yen C.-J.; YI-DER JIANG; Yen C.-J.; Chou W.-L.; Kuo S.-S.; Lee K.-C.; Chiu K.C.; Chuang L.-M. |
| 臺大學術典藏 |
2020-06-17T05:21:30Z |
Interaction of the G182C polymorphism in the APOA5 gene and fasting plasma glucose on plasma triglycerides in Type 2 diabetic subjects
|
YI-DER JIANG;Chuang L.-M.;Chiu K.C.;Lee K.-C.;Kuo S.-S.;Chou W.-L.;Yen C.-J.; YI-DER JIANG; Yen C.-J.; Chou W.-L.; Kuo S.-S.; Lee K.-C.; Chiu K.C.; Chuang L.-M. |
| 臺大學術典藏 |
2020-06-01T06:57:14Z |
Immediate knowledge improvement and long-term teaching confidence after general medicine faculty training program
|
Tseng F.-Y.;Lin L.-C.;Ko B.-S.;Chu T.-S.;Tsai S.-L.;Sheng W.-H.;Yen C.-J.;Chang C.-H.;Wu C.-H.;Shyang-Rong Shih;Chiu W.-Y.;Pan S.-C.;Chen W.-P.;Chang P.-Y.; Tseng F.-Y.; Lin L.-C.; Ko B.-S.; Chu T.-S.; Tsai S.-L.; Sheng W.-H.; Yen C.-J.; Chang C.-H.; Wu C.-H.; SHYANG-RONG SHIH; Chiu W.-Y.; Pan S.-C.; Chen W.-P.; Chang P.-Y. |
| 臺大學術典藏 |
2020-06-01T04:30:51Z |
Interaction of the G182C polymorphism in the APOA5 gene and fasting plasma glucose on plasma triglycerides in Type 2 diabetic subjects
|
LEE-MING CHUANG;Chiu K.C.;Lee K.-C.;Kuo S.-S.;Chou W.-L.;Yen C.-J.;Jiang Y.-D.; Jiang Y.-D.; Yen C.-J.; Chou W.-L.; Kuo S.-S.; Lee K.-C.; Chiu K.C.; LEE-MING CHUANG |
| 臺大學術典藏 |
2020-06-01T03:55:31Z |
Immediate knowledge improvement and long-term teaching confidence after general medicine faculty training program
|
Fen-Yu Tseng;Lin L.-C.;Ko B.-S.;Chu T.-S.;Tsai S.-L.;Sheng W.-H.;Yen C.-J.;Chang C.-H.;Wu C.-H.;Shih S.-R.;Chiu W.-Y.;Pan S.-C.;Chen W.-P.;Chang P.-Y.; FEN-YU TSENG; Lin L.-C.; Ko B.-S.; Chu T.-S.; Tsai S.-L.; Sheng W.-H.; Yen C.-J.; Chang C.-H.; Wu C.-H.; Shih S.-R.; Chiu W.-Y.; Pan S.-C.; Chen W.-P.; Chang P.-Y. |
| 臺大學術典藏 |
2020-05-26T09:26:57Z |
A phase i study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies
|
Lin C.-C;Su W.-C;Yen C.-J;Hsu C.-H;Su W.-P;Yeh K.-H;Lu Y.-S;Cheng A.-L;Huang D.C.-L;Fritsch H;Voss F;Taube T;Chih-Hsin Yang; Lin C.-C; Su W.-C; Yen C.-J; Hsu C.-H; Su W.-P; Yeh K.-H; Lu Y.-S; Cheng A.-L; Huang D.C.-L; Fritsch H; Voss F; Taube T; CHIH-HSIN YANG |
| 臺大學術典藏 |
2020-05-26T03:25:53Z |
Old age is a positive modifier of renal outcome in Taiwanese patients with stages 3–5 chronic kidney disease
|
Yu-Hsiang Chou;Yen C.-J.;Lai T.-S.;Chen Y.-M.; YU-HSIANG CHOU; Yen C.-J.; Lai T.-S.; Chen Y.-M. |
| 臺大學術典藏 |
2020-05-25T07:35:22Z |
A phase i study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies
|
Chia-Chi Lin; Su W.-C; Yen C.-J; Hsu C.-H; Su W.-P; Yeh K.-H; Lu Y.-S; Cheng A.-L; Huang D.C.-L; Fritsch H; Voss F; Taube T; Yang J.C.-H. |
| 臺大學術典藏 |
2020-05-25T07:35:00Z |
Phase I Dose-Escalation and -Expansion Study of Telisotuzumab (ABT-700), an Anti-c-Met Antibody, in Patients with Advanced Solid Tumors
|
Ansell P; Motwani M; Wong S; Yue H; Wang L; Reilly E; Afar D; Naumovski L; Ramanathan R.K.; Strickler J.H; LoRusso P; Salgia R; Kang Y.-K; Yen C.J; Chia-Chi Lin |
| 臺大學術典藏 |
2020-05-25T07:35:00Z |
Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours
|
Bogenrieder T; Twelves C; Cheng A.-L.; Huang D.C.-L; Strelkowa N; Goeldner R.-G; Schmid U; Fuertig R; Buschke S; Jove M; Anthoney A; Yen C.-J; de Bono J; Chia-Chi Lin; Chen L.-T; Corral J; Michalarea V; Rihawi K; Ong M; Lee J.-H; Hsu C.-H; Yang J.C.-H; Shiah H.-S |
| 臺大學術典藏 |
2020-05-25T06:51:54Z |
A phase i study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies
|
Lin C.-C;Su W.-C;Yen C.-J;Hsu C.-H;Su W.-P;Yeh K.-H;Yen-Shen Lu;Cheng A.-L;Huang D.C.-L;Fritsch H;Voss F;Taube T;Yang J.C.-H.; Lin C.-C; Su W.-C; Yen C.-J; Hsu C.-H; Su W.-P; Yeh K.-H; YEN-SHEN LU; Cheng A.-L; Huang D.C.-L; Fritsch H; Voss F; Taube T; Yang J.C.-H. |
